"Prime-Boost" Vaccine Schedule for Prevention of HIV Infection

NCT00109629 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

NIH

Sponsor class

Conditions

HIV Infections

Interventions

DRUG: VRC-HIVDNA016-00-VP
DRUG: VRC-HIVADV014-00

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)